Ziegler Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$11.8M Buy
162,381
+104,759
+182% +$7M 0.45% 61
2023
Q4
$3.53M Sell
57,622
-113,836
-66% -$6.76M 0.16% 153
2023
Q3
$9.81M Buy
171,458
+546
+0.3% +$33K 0.39% 85
2023
Q2
$10.2M Sell
170,912
-43,417
-20% -$2.6M 0.39% 83
2023
Q1
$13.4M Sell
214,329
-2,061
-1% -$129K 0.53% 44
2022
Q4
$13.5M Buy
216,390
+38,307
+22% +$2.2M 0.57% 37
2022
Q3
$8.87M Buy
178,083
+59,857
+51% +$3.31M 0.39% 85
2022
Q2
$6.95M Buy
+118,226
New +$6.52M 0.29% 129

Other funds holding PBH

Ziegler Capital Management's PBH Position: Q1 2024 in Review

Ziegler Capital Management increased its Prestige Consumer Healthcare (PBH) stake by 182% in Q1 2024, buying an estimated $7M and bringing the position to 162,381 shares worth $11.8M. The position accounts for 0.45% of the portfolio, ranked #61.

Ziegler Capital Management first reported a position in PBH in Q2 2022 and has held it in 8 quarters since. The position peaked at $13.5M in Q4 2022. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.

  • Ziegler Capital Management held 162,381 shares of Prestige Consumer Healthcare worth $11.8M as of Q1 2024.
  • Ziegler Capital Management bought 104,759 Prestige Consumer Healthcare shares in Q1 2024, an estimated $7M.
  • Prestige Consumer Healthcare made up 0.45% of Ziegler Capital Management's portfolio in Q1 2024, its #61 holding.
  • Ziegler Capital Management first reported a position in Prestige Consumer Healthcare in Q2 2022 and has held it in 8 quarters since.
  • Ziegler Capital Management's Prestige Consumer Healthcare position peaked at $13.5M in Q4 2022.
  • 312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.